𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A bispecific chimeric antigen receptor targeting antigen escape variants in glioblastoma

✍ Scribed by Hegde, M.; Corder, A.; Grada, Z.; Byrd, T.T.; Chow, K.K.; Brawley, V.S.; Krebs, S.S.; Heslop, H.; Gottschalk, S.; Yvon, E.; Ahmed, N.

Book ID
122110775
Publisher
Informa plc
Year
2014
Tongue
English
Weight
52 KB
Volume
16
Category
Article
ISSN
1465-3249

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Role of target antigen in bispecific-ant
Role of target antigen in bispecific-antibody-mediated killing of human glioblastoma cells: A pre-clinical study
✍ Achim Pfosser; Martina Brandl; Helmut Salih; Ludger Grosse-Hovest; Gundram Jung πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 85 KB πŸ‘ 1 views

Bispecific antibodies (bsAbs) directed to tumor-associated antigens and to receptors mediating T-cell activation, such as the TCR/CD3 complex and the co-stimulatory CD28 molecule, are capable of activating T cells at the surface of tumor cells, resulting in tumor-cell killing. Here we report the pre

Chimeric Antigen Receptor T Cells for Su
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
✍ Maude, Shannon L.; Frey, Noelle; Shaw, Pamela A.; Aplenc, Richard; Barrett, Davi πŸ“‚ Article πŸ“… 2014 πŸ› Massachusetts Medical Society 🌐 English βš– 661 KB

## Background: Relapsed acute lymphoblastic leukemia (all) is difficult to treat despite the availability of aggressive therapies. chimeric antigen receptor-modified t cells targeting cd19 may overcome many limitations of conventional therapies and induce remission in patients with refractory disea